Voyager Therapeutics to Participate in Upcoming Investor Conferences
03 September 2021 - 7:08AM
Voyager Therapeutics, Inc. (Nasdaq: VYGR), a gene therapy company
developing life-changing treatments and next-generation platform
technologies, today announced that it will participate in the
following upcoming virtual investor conferences.
- Wells Fargo Securities Healthcare Conference, fireside chat,
Sept. 9, 2021, 2:00 p.m. ET
- Morgan Stanley Global Healthcare Conference, fireside chat,
Sept. 14, 2021, 2:00 p.m. ET
- Baird Global Healthcare Conference, company presentation, Sept.
15, 2021, 8:30 a.m. ET
The sessions may be accessed from the Investors & Media
section of Voyager’s website at www.voyagertherapeutics.com.
Replays of the webcasts will be archived on the Company's website
for at least 30 days.
About Voyager TherapeuticsVoyager Therapeutics
(Nasdaq: VYGR) is leading the next generation of AAV gene therapy
to unlock the potential of the technology to treat devastating
diseases. Proprietary capsids born from the Company’s TRACER™
screening platform are powering a rich early-stage pipeline of new
and second-generation programs and may elevate the field to
overcome the limitations of conventional gene therapy vectors
across neurological disorders and other therapeutic areas.
voyagertherapeutics.com
LinkedIn
Twitter
Investor
Inquiries: investors@voyagertherapeutics.com
Media
Inquiries: Scott
Santiamossantiamo@voyagertherapeutics.com
Voyager Therapeutics (NASDAQ:VYGR)
Historical Stock Chart
From Apr 2024 to May 2024
Voyager Therapeutics (NASDAQ:VYGR)
Historical Stock Chart
From May 2023 to May 2024